Liz Paxton, PhD is the director of Kaiser Permanente’s national implant registry program in the United States and led the development of this post-market surveillance program for over 12 million members nationwide. She is a recognized an expert in registry development, implementation, registry science, and outcome assessment with presentations to a wide variety of audiences including FDA public workshops, Academy Health meetings, American Medical Association, national/international orthopedic, and health technology groups. She served on the Institute of Medicine’s committee evaluating the Public Health Effectiveness of the FDA 510(k) Clearance Process, the National Medical Device Registries Task Force, and is a member of the Medical Device Epidemiology Network. She serves as co-director of the FDA’s International Consortium of Orthopedic Registries and OrthoCRN responsible for developing a network of national and international registries for FDA postmarket surveillance of orthopedic devices. Dr. Paxton is also the current president of the International Society of Arthroplasty Registries. She has over 120 publications on registry development, identification of patient risk factors for adverse events, comparative effectiveness and surveillance of medical devices.